Alprostadil / Atropine / Papaverine / Phentolamine Solution

This advanced four-component formulation leverages the therapeutic synergy of alprostadil, atropine, papaverine, and phentolamine to achieve potent smooth muscle relaxation through multiple distinct pharmacological pathways. By simultaneously inhibiting alpha-adrenergic vasoconstriction and increasing intracellular signaling for vasodilation, the combination provides a robust clinical response for patients who are refractory to conventional monotherapy. The administration as a localized solution ensures a rapid onset of action and allows for precise, patient-specific titration to optimize efficacy while minimizing the risk of systemic adverse effects.